New drug IGT-303 enters safety testing for kidney disease
Disease control
Recruiting now
This study is testing whether a new drug called IGT-303 is safe for people with chronic kidney disease. It will involve 94 healthy volunteers and people with kidney disease, who will receive either the drug or a placebo. The main goal is to check for side effects and how the drug…
Phase: PHASE1, PHASE2 • Sponsor: Ingenia Therapeutics INC • Aim: Disease control
Last updated May 17, 2026 04:10 UTC